Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
Acute, single exposure
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data
Justification for type of information:
Primary source from peer-reviewed journal.
Handbook source from United Nations CICAD report, Concise International Chemical Assessment Document 25, 2000
The substance carries a harmonised classification for acute oral toxicity

Data source

Reference
Reference Type:
publication
Title:
Fate of 2,2,2-trichloroacetaldehyde, (chloral hydrate) produced during trichloroethylene, oxidation by methanotrophs
Author:
Newman LM, Wackett LP
Year:
1991
Bibliographic source:
Applied and environmental microbiology, 57:2399–2402

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Version / remarks:
Mice
GLP compliance:
not specified
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
2,2,2-trichloroethane-1,1-diol
EC Number:
206-117-5
EC Name:
2,2,2-trichloroethane-1,1-diol
Cas Number:
302-17-0
Molecular formula:
C2H3Cl3O2
IUPAC Name:
2,2,2-trichloroethane-1,1-diol
Test material form:
solid: granular

Test animals

Species:
mouse
Strain:
CD-1
Sex:
male/female

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Doses:
300, 600, 900, 1200, 1500, and 1800 mg/kg body weight
No. of animals per sex per dose:
8 male, 8 female
Control animals:
not specified

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LD0
Effect level:
ca. 900 mg/kg bw
Based on:
test mat.
Sex:
female
Dose descriptor:
LD50
Effect level:
ca. 1 265 mg/kg bw
Based on:
test mat.
Sex:
male
Dose descriptor:
LD50
Effect level:
ca. 1 442 mg/kg bw
Based on:
test mat.
Key result
Sex:
male/female
Dose descriptor:
discriminating dose
Effect level:
< 300 mg/kg bw
Based on:
test mat.
Remarks on result:
other: Sedation observed at all dose levels and considered to be an adverse effect
Mortality:
Yes, at higher dose groups and all within 24 hours of administration
No mortality at 900 mg/kg or lower
Clinical signs:
other: Yes; lethagy and sedation observed within minutes of administration
Gross pathology:
None reported
Other findings:
Sedation occured at 300 mg/kg and higher, with effects observed within minutes of administration.

Any other information on results incl. tables

The mice became sedated at 300 mg/kg body weight. At 600 and 900 mg/kg the animals became lethargic and exhibited loss of righting reflex.

Respiration was markedly inhibited at 1200, 1500, and 1800 mg/kg.

Inhibition of respiration appeared to be the immediate cause of death

Applicant's summary and conclusion

Interpretation of results:
Category 3 based on GHS criteria
Conclusions:
Other acute oral studies are cited in the UN CICAD report, with Rat LD50 considered to be 480 mg/kg.
In view of the harmonised classification, further testing is not justified.